My eGFR Drops Every Year but I Feel Fine — Is There Really Nothing to Be Done About My Chronic Kidney Disease?

It was a routine blood test. The doctor pointed to the creatinine number, then to the eGFR, and said your kidneys aren't filtering like they used to. You asked what to do. The answer: "Watch and wait. We'll check again in six months." Six months later, the number had dropped again. And the answer was the same.

Two things are true at once.

Chronic Kidney Disease is serious — it is progressive, it can lead to dialysis or transplant, and every nephron lost is gone for good. Nobody should pretend otherwise.

But "there's nothing we can do until it gets worse" is no longer the full picture. In the DAPA-CKD trial, dapagliflozin reduced the risk of worsening kidney function, end-stage kidney disease, or renal death by 39% across patients with and without diabetes (Heerspink et al., 2020, NEJM). Blood pressure management with ACE inhibitors and ARBs has been slowing proteinuric CKD progression for over two decades. Dietary protein restriction is now supported by growing evidence as a way to reduce glomerular hyperfiltration. This is not a miracle — it does not stop the disease for everyone. But the old script of "just wait for dialysis" is outdated.

What if the reason CKD still feels like a dead end isn't that nothing works — but that no single system sees the whole picture? Four medical traditions each catch something the others miss about why kidneys decline and what might slow it down. Rebirthealth brings those perspectives into one conversation.

Modern Medicine

Modern medicine looks at your kidneys through numbers and trajectories — your eGFR trend, your proteinuria, and how fast both are moving.

They would ask: What is your eGFR trend over the past year? What is your urine albumin-to-creatinine ratio? Are you on an ACE inhibitor or ARB? What does your blood pressure look like day to day?

The direction is slowing progression through blood pressure control, SGLT2 inhibitors, and dietary protein management. Dapagliflozin reduced the composite renal endpoint by 39% in the DAPA-CKD trial — a finding that has reshaped how nephrologists think about early intervention (Heerspink et al., 2020, PMID: 32970396). ACE inhibitors and ARBs have become standard for proteinuric CKD by reducing intraglomerular pressure. Dietary protein restriction to approximately 0.6–0.8 g/kg/day is increasingly adopted to reduce hyperfiltration stress on remaining nephrons.

This does not replace your current medical care.

Traditional Chinese Medicine

Traditional Chinese medicine looks at your whole body's energy, fluid metabolism, and circulation — reading the patterns that lab numbers alone don't capture.

They would ask: Is there persistent fatigue and poor appetite? Is there swelling around the ankles by evening? Is the urine persistently foamy? Does the tongue appear pale, swollen, with teeth marks along the edges?

The direction is strengthening the spleen and kidney, transforming dampness, and invigorating blood circulation — tailored to the individual's pattern presentation. TCM frameworks describe CKD through patterns of spleen-kidney qi deficiency, dampness-turbidity obstructing the middle burner, and blood stasis blocking the collaterals. A 2022 review in Frontiers in Pharmacology mapped these pattern-based approaches to modern mechanisms including anti-inflammatory and anti-fibrotic pathways (Wang et al., 2022, PMID: 35924053).

This does not replace your current medical care.

Ayurveda

Ayurveda sees the kidney as a seat of Meda Dhatu — the fatty metabolic tissue — and reads kidney decline as a systemic imbalance of Vata and Kapha, with ama (metabolic residue) accumulating in the channels.

They would ask: Is digestion sluggish — bloating, irregular appetite, heavy feeling after meals? Is there swelling, heaviness in the limbs, and a sense of lethargy? What is the urine pattern — frequency, color, output volume?

The direction is balancing Vata and Kapha, reducing ama, and supporting kidney function through dietary modification and herbal support. Ayurvedic practitioners view declining kidney function as the downstream result of impaired digestion and metabolic residue clogging the body's channels. A clinical study of 100 CKD patients found that Ayurvedic management alongside standard care showed improvements in subjective symptoms and renal parameters (Patel et al., 2011, PMID: 22661841).

This does not replace your current medical care.

Mind-Body / Stress Physiology

Mind-body medicine looks at the invisible pressure your nervous system puts on your kidneys every day — chronic stress driving sympathetic overactivity, which constricts renal blood vessels and accelerates decline.

They would ask: Is chronic stress keeping blood pressure elevated even when medications are in place? How is sleep — fragmented, restless, never restorative? What is the emotional weight of carrying a progressive diagnosis with no clear endpoint?

The direction is autonomic regulation to reduce the sympathetic burden on the kidneys, and stress-immune modulation to lower inflammatory drivers of progression. Chronic sympathetic overactivity triggers renal vasoconstriction, sodium retention, and activation of the renin-angiotensin system — all of which compound kidney damage over time (Kaur et al., 2017, PMID: 28767097). The HPA axis, when chronically activated by stress, elevates cortisol, drives blood pressure higher, and fuels systemic inflammation that further injures nephrons.

This does not replace your current medical care.

These four pairs of eyes have never been put together, looking at the same person, at the same time. You've already tried one or two of these 'adjustments' — but there are others that have never truly looked at you. That may be the door you haven't opened yet.

	Modern Medicine	TCM	Ayurveda	Mind-Body
Looks at	eGFR trajectory, proteinuria, BP	Qi patterns, dampness, blood stasis	Vata-Kapha balance, ama, Meda Dhatu	Sympathetic overactivity, HPA axis
Asks about	Labs, medications, BP readings	Fatigue, swelling, tongue, appetite	Digestion, urine pattern, heaviness	Stress load, sleep, emotional burden
Direction	Slow progression via BP control, SGLT2 inhibitors, protein restriction	Strengthen spleen-kidney, transform dampness, invigorate blood	Balance Vata-Kapha, reduce ama, dietary modification	Reduce sympathetic renal impact, stress-immune modulation
Strength	Validated drug targets, precise monitoring	Whole-body pattern reading	Digestive-metabolic root focus	Addresses the stress-kidney feedback loop

FAQ

Can Chronic Kidney Disease be reversed?

No one who hasn't examined you in detail can guarantee a specific outcome — anyone who does is worth being suspicious of. CKD involves permanent nephron loss — damaged nephrons do not regenerate. What is possible, especially in earlier stages, is meaningfully slowing the rate of decline. SGLT2 inhibitors, blood pressure control, and dietary protein management have all demonstrated the ability to delay progression. The goal is preserving the kidney function you still have for as long as possible.

What does "watch and wait" actually mean for CKD?

"Watch and wait" means monitoring your eGFR, urine albumin, and blood pressure at regular intervals — typically every three to six months. It does not mean doing nothing. During this period, lifestyle changes, blood pressure management, and dietary adjustments can all influence the trajectory. The frustration many people feel is that "watching" can feel like the only thing on offer — but it is the baseline, not the ceiling.

How fast does CKD usually progress?

Progression varies widely. Some people lose 1–2 mL/min of eGFR per year; others decline much faster. Factors that accelerate progression include uncontrolled blood pressure, heavy proteinuria, diabetes, and high dietary protein intake. Factors that slow it include ACE inhibitors or ARBs, SGLT2 inhibitors, and blood pressure control. The range of possible trajectories is why personalized monitoring matters more than averages.

Can stress really affect my kidneys?

Yes. Chronic stress activates the sympathetic nervous system, which constricts blood vessels in the kidneys and reduces renal blood flow. Over time, this contributes to higher blood pressure, sodium retention, and further kidney strain. The HPA axis also elevates cortisol, which drives inflammation. Stress is not the primary cause of CKD, but it is a modifiable factor that can influence how fast the disease progresses.

Is it too late to do anything if my eGFR is already low?

It is not too late until your nephrologist tells you it is. Even at lower eGFR levels, interventions can slow further decline and improve quality of life. Blood pressure control, dietary protein management, and addressing stress and sleep can all make a difference. The question is not whether it's too late — it's what still can be done with what you have.

Next Steps

If you are reading this, you are already doing more than "watching and waiting." Here is what you can do next:

1. Gather your data. Collect your last three to five lab results. Plot your eGFR trend. Know your urine albumin-to-creatinine ratio.

2. Check your medications. Are you on an ACE inhibitor or ARB? Ask your nephrologist whether an SGLT2 inhibitor is appropriate for your stage.

3. Look at your blood pressure. Log it daily for two weeks. Bring the log to your next appointment.

4. Examine your stress and sleep. These are not side issues — they directly affect your sympathetic nervous system and your kidneys.

5. Bring all four perspectives together. Modern medicine, TCM, Ayurveda, and mind-body physiology each see a layer the others miss.

Rebirthealth brings those perspectives into one conversation — so you can see the full picture of what's possible for your CKD.

This article is for informational purposes only and is not medical advice. Chronic Kidney Disease requires ongoing management by a qualified nephrologist. Do not change medications or begin new approaches without professional guidance.

The content reflects general knowledge from multiple medical traditions and does not constitute a recommendation for any specific therapy or supplement. Individual results vary.

References

1. Heerspink HJL, Stefánsson BV, Correa-Rotter R, et al. Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2020;383(15):1436-1446. PMID: 32970396.

2. Wang Y, Feng Y, Li M, et al. Traditional Chinese Medicine in the Treatment of Chronic Kidney Diseases: Theories, Applications, and Mechanisms. Front Pharmacol. 2022;13:917185. PMID: 35924053.

3. Patel MV, Gupta SN, Patel NG. Effects of Ayurvedic treatment on 100 patients of chronic renal failure (other than diabetic nephropathy). Ayu. 2011;32(4):528-533. PMID: 22661841.

4. Kaur J, Young BE, Fadel PJ. Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms. Int J Mol Sci. 2017;18(8):1682. PMID: 28767097.

---

You found this page because a routine lab result changed everything. The "watch and wait" you were told was the beginning — not the ending. People with CKD who gathered all four perspectives discovered there was more to be done than anyone had told them. The numbers on that lab slip were the start of a longer story — and it's still being written.